Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (DE:CVS)
XETRA:CVS
Holding DE:CVS?
Track your performance easily
CVS Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€41.68 - €75.52
Previous Close€42.82
Volume552.00
Average Volume (3M)1.55K
Market Cap
€54.28B
Enterprise Value€124.02B
Total Cash (Recent Filing)$9.68B
Total Debt (Recent Filing)$82.70B
Price to Earnings (P/E)11.7
Beta0.22
Next Earnings
Feb 05, 2025EPS Estimate
€0.96Last Dividend Ex-Date
Oct 21, 2024Dividend Yield5.98%
Share Statistics
EPS (TTM)3.65
Shares Outstanding1,258,407,645
10 Day Avg. Volume2,494
30 Day Avg. Volume1,549
Standard Deviation0.07
R-Squared0.08
Alpha0.00281
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.72
Price to Sales (P/S)0.15
Price to Cash Flow (P/CF)-19.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.34
Enterprise Value/Gross Profit2.28
Enterprise Value/Ebitda13.90
Forecast
1Y Price Target
€62.32Price Target Upside45.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
CVS Health News
Bulls Say, Bears Say
Bulls Say
Medicare Advantage OpportunitiesPotential for strong specialty pharmacy growth and a return to historic MA trend levels could drive mid-teens adjusted EPS growth.
Pharmacy Benefit Managers ReformsPharmacy benefit manager reforms are aimed at ensuring accountability, increasing oversight, and prohibiting abusive practices, which could lead to greater transparency in the industry.
Valuation And Growth PotentialAnalyst reiterates a Buy rating as CVS shares trade at a low valuation, offering potential upside despite risks.
Bears Say
Financial PerformanceThe estimated adjusted earnings per share for 2024 and 2025 have been revised down from previous expectations.
Macroeconomic ImpactsMacro headwinds are impacting Health Care Benefits, Oak Street, and Pharmacy & Consumer Wellness, leading to lowered estimates.
Regulatory ChallengesProvisions on PBM reforms require greater transparency on drug pricing, which could impact CVS operations.
---
Ownership Overview
1.04% Insiders
29.50% Mutual Funds
25.91% Other Institutional Investors
22.70% Public Companies and
Individual Investors
Website Traffic
The estimated number of people who visited one or more of the websites owned by CVS Health
Desktop Users
Mobile Users
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €41.68 and its highest was €75.52 in the past 12 months.
What is CVS Health Corp’s market cap?
Currently, no data Available
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Feb 05, 2025 which is in 38 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Nov 06, 2024. The company reported €1.048 earnings per share for the quarter, missing the consensus estimate of €1.38 by -€0.333.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of €0.639 which represents an annual dividend yield of 5.98%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is €0.96.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,258,407,600 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of €1.048 in its last earnings report, missing expectations of €1.38. Following the earnings report the stock price went up 13.339%.
Which hedge fund is a major shareholder of CVS Health Corp?
Among the largest hedge funds holding CVS Health Corp’s share is Dodge & Cox. It holds CVS Health Corp’s shares valued at 4B.
---
CVS Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€62.32 (45.53% Upside)
€62.32 (45.53% Upside)
Blogger Sentiment
Bullish
DE:CVS Sentiment 79%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.19%
12-Months-Change
Fundamentals
Return on Equity
6.72%
Trailing 12-Months
Asset Growth
0.45%
Trailing 12-Months
Company Description
CVS Health Corp
Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.
---
CVS Company Deck
---
CVS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging environment with significant issues in the Health Care Benefits segment, including elevated utilization and mispricing in Medicare and individual exchange products. However, there are strong performances in the Pharmacy and Consumer Wellness, Health Services, and Health Care Delivery segments, driving optimism for future growth.Read More>---
CVS Revenue Breakdown
52.22% Health Services
32.64% Pharmacy & Consumer Wellness
29.53% Health Care Benefits
0.13% Corporate/ Other
---
CVS Stock 12 Month Forecast
Average Price Target
€62.32
▲(45.53% Upside)
Technical Analysis
Best Analysts Covering CVS
1 Year
1 Year Success Rate
14/28 ratings generated profit
1 Year Average Return
+3.40%
reiterated a buy rating 8 months ago
Copying John Ransom's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.40% per trade.
---